Purpose: Candidate selection and donor allocation should promote equitable access to heart transplantation (HTX) according to patients’ needs, avoiding HTX in patients (pts) who are too well or too sick to get benefit. The national HTX database was analyzed to identify which variables were related to the competing events of getting HTX or dying on the waiting list (WL), and to post-transplant survival. Methods: Pts aged 14 years or more, who were listed for primary HTX from May 2012 and December 2016, were followed until January 2018, death or delisting for worsening. The incidence of death on the WL or of HTX were analyzed according to Aalen-Johansen method. Post-HTX survival was evaluated with Kaplan-Meyer method. Univariate and multivari...
BACKGROUND: Only half of the patients waiting for a heart transplant undergo surgery, whereas severa...
Whether patients with advancedheart failure and diabetes melli-tus (DM) should be listed for heart t...
Heart transplantation has become the treatment of choice for patients with end-stage heart diseases....
Purpose: Candidate selection and donor allocation should promote equitable access to heart transplan...
ObjectivesWe sought to investigate the actual survival of patients with end-stage heart failure list...
Objectives: A heart transplant (Htx) remains the gold standard treatment for patients with advanced ...
Importance: With continuing improvements in medical devices and more than a decade since the 2006 Un...
International audienceBackground. Heart transplantation is the gold-standard treatment for end-stage...
Background:The US heart allocation system ranks candidates using six categorical status levels. Tran...
Background: The U.S. heart allocation system ranks candidates with only 6 treatment-based categoric...
Introduction. Patients with terminal heart failure have increased more than the available organs lea...
ObjectivesThe aim of this study was to assess the survival benefit from heart transplantation (HT), ...
AbstractMany patients are accepted for cardiac transplantation during a period of clinical instabili...
International audienceSeveral risk scores exist to help identify best candidate recipients for heart...
BACKGROUND: Our purpose was to establish whether patients on the waiting list for heart-lung or lung...
BACKGROUND: Only half of the patients waiting for a heart transplant undergo surgery, whereas severa...
Whether patients with advancedheart failure and diabetes melli-tus (DM) should be listed for heart t...
Heart transplantation has become the treatment of choice for patients with end-stage heart diseases....
Purpose: Candidate selection and donor allocation should promote equitable access to heart transplan...
ObjectivesWe sought to investigate the actual survival of patients with end-stage heart failure list...
Objectives: A heart transplant (Htx) remains the gold standard treatment for patients with advanced ...
Importance: With continuing improvements in medical devices and more than a decade since the 2006 Un...
International audienceBackground. Heart transplantation is the gold-standard treatment for end-stage...
Background:The US heart allocation system ranks candidates using six categorical status levels. Tran...
Background: The U.S. heart allocation system ranks candidates with only 6 treatment-based categoric...
Introduction. Patients with terminal heart failure have increased more than the available organs lea...
ObjectivesThe aim of this study was to assess the survival benefit from heart transplantation (HT), ...
AbstractMany patients are accepted for cardiac transplantation during a period of clinical instabili...
International audienceSeveral risk scores exist to help identify best candidate recipients for heart...
BACKGROUND: Our purpose was to establish whether patients on the waiting list for heart-lung or lung...
BACKGROUND: Only half of the patients waiting for a heart transplant undergo surgery, whereas severa...
Whether patients with advancedheart failure and diabetes melli-tus (DM) should be listed for heart t...
Heart transplantation has become the treatment of choice for patients with end-stage heart diseases....